SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently generating significant market attention due to emerging reports that tech giants Google and Nvidia are considering the company as a key backup manufacturer for AI chips to address supply chain constraints. The community is intensely debating these strategic partnerships and the potential for Intel's 18A process to play a larger role in AI infrastructure, with bulls highlighting the long-term foundry growth thesis while bears express skepticism regarding immediate execution.

Optical Cable Corp. engages in the business of manufacturing fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment, specialty markets, and the wireless carrier market offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. Its products include fiber optic and copper cabling, hybrid cabling, fiber optic and copper connectors, specialty fiber optic, copper and hybrid connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multimedia boxes, fiber optic reels, and other cable and connectivity management accessories. The company was founded on June 10, 1983 and is headquartered in Roanoke, VA.

Optical Cable Corp.

Optical Cable Corp. is gaining momentum as investors eye its role in the critical fiber optic infrastructure required for data center expansion and 5G deployment. Community discussions are currently dominated by debates over the stock's low float potential and its long-term outlook as a beneficiary of increased enterprise connectivity demand.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a surge in trading activity driven by the massive expansion of its project pipeline and manufacturing capacity to support the increasing power demands of AI data centers. The community is actively debating the stock's potential as an infrastructure play while remaining highly focused on the company's ability to convert its growing proposal backlog into signed, profitable contracts.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning, Inc. is surging following a landmark multi-year partnership with Nvidia to significantly expand U.S. manufacturing capacity for optical connectivity and fiber-optic infrastructure required for AI data centers. Investors and community members are actively discussing the stock's role as a critical 'picks and shovels' play, with many noting that the company's glass and fiber technologies are essential for the horizontal scaling of modern AI infrastructure.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Nurix Therapeutics is surging as the community celebrates a major global collaboration with Roche to co-develop the oral BTK degrader bexobrutideg, a deal providing significant upfront cash and long-term milestone potential. Investors are actively discussing the de-risked financial outlook and the stock's massive market opportunity, with many viewing the partnership as strong external validation of the companys drug degradation platform.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly shares are surging as positive Phase 3 clinical trial results for its triple-agonist obesity drug, retatrutide, confirm best-in-class efficacy for weight loss and cardiometabolic health. The community is actively discussing the drug's potential to set a new benchmark in the weight-loss market, even as investors weigh the balance between record-breaking trial data and the long-term competitive dynamics within the GLP-1 sector.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is currently experiencing heightened volatility as investors weigh the impacts of rising treasury yields and shifting geopolitical tensions in the Middle East against a broader bullish sentiment surrounding AI infrastructure demand. The community is actively debating the sustainability of the current tech rally while monitoring key technical support levels and awaiting pivotal economic data that could determine the near-term direction for leveraged ETFs.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup is attracting attention as it is removed from the S&P 500 while investors closely monitor its dividend sustainability and potential for a turnaround after recent earnings. The community is actively debating the stock's defensive value at multi-year lows, with many seeing it as a potential long-term play or a buyout candidate despite ongoing headwinds from weak consumer demand and sector-wide pressures.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant momentum and investor interest, fueled by a high short interest and anticipation surrounding its critical role in supplying silicon carbide technology for next-gen AI data center infrastructure. The community is actively debating the stock's potential for a major short squeeze, with many pointing to its limited float and strategic position in the power semiconductor supply chain as key drivers for long-term upside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk Inc. is seeing intense volatility and social media attention as investors weigh recent leadership changes, including the appointment of a new CFO, against persistent downward price pressure. The community remains deeply divided, with many traders discussing potential short squeezes due to high short interest, while others express frustration over management and the stock's failure to sustain upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With CNS Pharmaceuticals Stock On Wednesday?

CNS Pharmaceuticals plans a pivot to an acquisition-led strategy, capital raise, and technicals signal momentum with caution.read more...

Best Small Cap Stocks To Keep An Eye On - May 4th

Direxion Daily MU Bull 2X Shares, Inflection Point Acquisition Corp. II, CNS Pharmaceuticals, Critical Metals, Elong Power, Direxion Daily PLTR Bear 1X Shares, and Spring Valley Acquisition are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stock...

Medical Stocks To Watch Today - May 4th

Arcellx, Eli Lilly and Company, UnitedHealth Group, CNS Pharmaceuticals, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in healthcare including pharmaceuticals, biotec...

Pharmaceutical Stocks To Follow Today - May 4th

Eli Lilly and Company, CNS Pharmaceuticals, Novo Nordisk A/S, Abbott Laboratories, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and sell...

Institutional Giants Are Piling into Four of These NASDAQ Plays

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

Why Did CNSP Stock Surge 330% Today?

Equity

The company announced a private placement, involving the sale of 650,000 common shares at $2.30 each, along with pre-funded warrants tied to over 9.1 million shares.

Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot

CNS Pharmaceuticals announces $22.5 million financing as the company pivots its strategy, eyes asset acquisitions.read more...

CNS Pharmaceuticals Secures $22.5 M in Oversubscribed Private Placement

CNS Pharmaceuticals (NASDAQ:CNSP) significantly boosted its capital reserves, entering into securities purchase agreements for a private placement expected to generate $22.5 million in gross proceeds.

CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved

The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.

This account has been verified as an official CNSP representative.

Verified Account

CNS Pharma

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Current Price	$4.91
Prev Close	$5.00
Open	$4.91
Dividend Yield	0.00%
50-Day Moving Average	$3.96
Beta	1.03
Avg. Volume	4.39M
PE Ratio	-0.17

52-Week High	$12.84
52-Week Low	$1.90
Market Capitalization	$7.31M
EPS (Annual)	-$35.75
Price to Book	57.39
Revenue Per Employee	$0.00

CNSPCns Pharmaceuticals Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest CNSP News